PHI with Lanolin allergy
How does this condition affect your private health insurance?
Wollwachsallergie, also known as lanolin allergy, is a type of allergic contact dermatitis triggered by an immune response to lanolin, a wax extracted from sheep's wool. This common allergen is present in numerous personal care products, cosmetics, topical medications, and some textiles. Upon exposure, individuals typically develop red, itchy, inflamed skin, often accompanied by blisters, swelling, or scaling at the contact site. Severity varies, from mild localized irritation to widespread eczematous eruptions. Diagnosis usually involves patch testing. Effective management centers on meticulous avoidance of lanolin-containing products. Symptomatic treatment includes topical corticosteroids and antihistamines to relieve inflammation and pruritus.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Typically resolves within 1-3 weeks with treatment and allergen avoidance.
Duration of Illness (Lifetime)
Episodic, dependent on exposure; can become chronic if continuous exposure occurs.
Cost of Treatment (Initial)
Low (e.g., topical corticosteroids, antihistamines; 20-100 EUR/USD).
Cost of Treatment (Lifetime)
Variable, typically low if avoidance is successful (0-500 EUR/USD), but higher with persistent exposure or severe reactions requiring specialized care.
Mortality Rate
Extremely low, practically zero due to the allergy itself.
Risk of Secondary Damages
Low (e.g., secondary bacterial infection from scratching, mild scarring, psychological impact from chronic rash). Anaphylaxis is extremely rare but theoretically possible.
Probability of Full Recovery
High, with strict avoidance of lanolin and appropriate symptomatic treatment.
Underlying Disease Risk
Higher incidence in individuals with pre-existing atopic dermatitis, eczema, or other forms of contact dermatitis.